SCHEMBL13720143

SCHEMBL13720143

CC(C)(C)OC(=O)NC[C@]1(c2ccccc2)C[C@H]1COCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.45
CTSS P25774 1/20 0.43
PPARA Q07869 2/20 0.43
IDO1 P14902 1/20 0.42
KLK7 P49862 2/20 0.41
KLK5 Q9Y337 2/20 0.41
NPFFR1 Q9GZQ6 1/20 0.39
NPFFR2 Q9Y5X5 1/20 0.39
PPARG P37231 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CTSL P07711 1/20 0.39
SIGMAR1 Q99720 2/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA7 P43166 1/20 0.38
CA14 Q9ULX7 1/20 0.38
KMT2A Q03164 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TACR1 P25103 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13720464 1.00 SYK (0.45) SYKCTSSPPARAIDO1KLK7
SCHEMBL13720411 1.00 SYK (0.45) SYKCTSSPPARAIDO1KLK7
SCHEMBL13720522 0.89 IDO1 (0.43) SYKCTSSPPARAIDO1KLK7
SCHEMBL13720294 0.89 IDO1 (0.43) SYKCTSSPPARAIDO1KLK7
SCHEMBL13720547 0.84 IDO1 (0.41) SYKCTSSIDO1NPFFR1NPFFR2
SCHEMBL6172551 0.84 ALDH1A1 (0.39) CTSSALDH1A1CTSLKMT2AMEN1
SCHEMBL4029654 0.80 L3MBTL1 (0.43) CTSSPPARACTSLL3MBTL1TACR1
SCHEMBL4028380 0.80 L3MBTL1 (0.43) CTSSPPARACTSLL3MBTL1TACR1
SCHEMBL14303457 0.78 IDO1 (0.40) SYKCTSSIDO1NPFFR1NPFFR2
SCHEMBL13720809 0.78 IDO1 (0.40) SYKCTSSIDO1NPFFR1NPFFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569579-B2 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome SMITHKLINE BEECHAM CORPORATION (US) 2009-08-04 US disclosed
US-7569579-B2 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome SMITHKLINE BEECHAM CORPORATION (US) 2009-08-04 US disclosed
EP-1569934-B1 CYCLOPROPYL COMPOUNDS AS CCR5 ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2008-01-23 EP disclosed